CFIC
GILD icon

City Financial Investment Company’s Gilead Sciences GILD Stock Holding History

City Financial Investment Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-56,407
Closed -$3.83M – 99
2017
Q1 		$3.83M Sell
56,407
-64,493
-53% -$4.53M 0.6% 37
2016
Q4 		$8.66M Buy
+120,900
New +$8.99M 1.59% 17

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

City Financial Investment Company's GILD Position: Q2 2017 in Review

City Financial Investment Company sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 56,407 shares — an estimated $3.83M sold.

City Financial Investment Company first reported a position in GILD in Q4 2016 and held it in 2 quarters. The position peaked at $8.66M in Q4 2016. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • City Financial Investment Company reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • City Financial Investment Company sold 56,407 Gilead Sciences shares in Q2 2017, an estimated $3.83M.
  • City Financial Investment Company first reported a position in Gilead Sciences in Q4 2016 and held it in 2 quarters.
  • City Financial Investment Company's Gilead Sciences position peaked at $8.66M in Q4 2016.
  • 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on City Financial Investment Company's 13F filing for Q2 2017, filed 14 Aug 2017.